Equity Research Valuation Notes for STC, Savola, Thales, and YANSAB

Equity Research Valuation Notes for STC, Savola, Thales, and YANSAB The passage contains internal analyst valuation methodology and market risk commentary for several companies. It does not mention any high‑profile individuals, government agencies, financial flows tied to political actors, or potential misconduct. Therefore it offers no actionable investigative leads. Key insights: Details valuation assumptions for STC, Savola, Thales, and YANSAB.; Mentions market risks such as competition, FX exposure, and Iranian revenue exposure.; Provides price objective calculations and multiples used.